BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16972228)

  • 1. Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.
    Pujo L; Fagart J; Gary F; Papadimitriou DT; Claës A; Jeunemaître X; Zennaro MC
    Hum Mutat; 2007 Jan; 28(1):33-40. PubMed ID: 16972228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism.
    Sartorato P; Khaldi Y; Lapeyraque AL; Armanini D; Kuhnle U; Salomon R; Caprio M; Viengchareun S; Lombès M; Zennaro MC
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):119-25. PubMed ID: 15134810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I.
    Geller DS; Rodriguez-Soriano J; Vallo Boado A; Schifter S; Bayer M; Chang SS; Lifton RP
    Nat Genet; 1998 Jul; 19(3):279-81. PubMed ID: 9662404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid resistance.
    Zennaro MC; Lombès M
    Trends Endocrinol Metab; 2004 Aug; 15(6):264-70. PubMed ID: 15358279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1.
    Riepe FG; Finkeldei J; de Sanctis L; Einaudi S; Testa A; Karges B; Peter M; Viemann M; Grötzinger J; Sippell WG; Fejes-Toth G; Krone N
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4552-61. PubMed ID: 16954160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular features of type 1 pseudohypoaldosteronism.
    Riepe FG
    Horm Res; 2009; 72(1):1-9. PubMed ID: 19571553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.
    Tajima T; Kitagawa H; Yokoya S; Tachibana K; Adachi M; Nakae J; Suwa S; Katoh S; Fujieda K
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4690-4. PubMed ID: 11134129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of the R947X mutation in unrelated families with autosomal dominant pseudohypoaldosteronism type 1: evidence for a mutational hot spot in the mineralocorticoid receptor gene.
    Fernandes-Rosa FL; de Castro M; Latronico AC; Sippell WG; Riepe FG; Antonini SR
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3671-5. PubMed ID: 16757525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudohypoaldosteronisms, report on a 10-patient series.
    Belot A; Ranchin B; Fichtner C; Pujo L; Rossier BC; Liutkus A; Morlat C; Nicolino M; Zennaro MC; Cochat P
    Nephrol Dial Transplant; 2008 May; 23(5):1636-41. PubMed ID: 18424465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic disorders caused by gain or loss of function of the mineralocorticoid receptor].
    Arai K; Shibasaki T
    Nihon Rinsho; 2002 Feb; 60(2):361-6. PubMed ID: 11857927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor mutations.
    Zennaro MC; Fernandes-Rosa F
    J Endocrinol; 2017 Jul; 234(1):T93-T106. PubMed ID: 28348114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different inactivating mutations of the mineralocorticoid receptor in fourteen families affected by type I pseudohypoaldosteronism.
    Sartorato P; Lapeyraque AL; Armanini D; Kuhnle U; Khaldi Y; Salomon R; Abadie V; Di Battista E; Naselli A; Racine A; Bosio M; Caprio M; Poulet-Young V; Chabrolle JP; Niaudet P; De Gennes C; Lecornec MH; Poisson E; Fusco AM; Loli P; Lombès M; Zennaro MC
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2508-17. PubMed ID: 12788847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for genetic heterogeneity of pseudohypoaldosteronism type 1: identification of a novel mutation in the human mineralocorticoid receptor in one sporadic case and no mutations in two autosomal dominant kindreds.
    Viemann M; Peter M; López-Siguero JP; Simic-Schleicher G; Sippell WG
    J Clin Endocrinol Metab; 2001 May; 86(5):2056-9. PubMed ID: 11344206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal-dominant pseudohypoaldosteronism type 1 in a Turkish family is associated with a novel nonsense mutation in the human mineralocorticoid receptor gene.
    Riepe FG; Krone N; Morlot M; Peter M; Sippell WG; Partsch CJ
    J Clin Endocrinol Metab; 2004 May; 89(5):2150-2. PubMed ID: 15126534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autosomal dominant pseudohypoaldosteronism type 1: mechanisms, evidence for neonatal lethality, and phenotypic expression in adults.
    Geller DS; Zhang J; Zennaro MC; Vallo-Boado A; Rodriguez-Soriano J; Furu L; Haws R; Metzger D; Botelho B; Karaviti L; Haqq AM; Corey H; Janssens S; Corvol P; Lifton RP
    J Am Soc Nephrol; 2006 May; 17(5):1429-36. PubMed ID: 16611713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exclusion of serum- and glucocorticoid-induced kinase 1 (SGK1) as a candidate gene for genetically heterogeneous renal pseudohypoaldosteronism type I in eight families.
    Riepe FG; Holterhus PM
    Am J Nephrol; 2007; 27(2):164-9. PubMed ID: 17317952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineralocorticoid receptor mutations differentially affect individual gene expression profiles in pseudohypoaldosteronism type 1.
    Fernandes-Rosa FL; Hubert EL; Fagart J; Tchitchek N; Gomes D; Jouanno E; Benecke A; Rafestin-Oblin ME; Jeunemaitre X; Antonini SR; Zennaro MC
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E519-27. PubMed ID: 21159846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mineralocorticoid resistance: pseudohypoaldosteronism type 1].
    Fernandes-Rosa FL; Antonini SR
    Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):373-81. PubMed ID: 17546235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone resistance: structural and functional considerations and new perspectives.
    Zennaro MC; Hubert EL; Fernandes-Rosa FL
    Mol Cell Endocrinol; 2012 Mar; 350(2):206-15. PubMed ID: 21664233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel nonsense mutation of the mineralocorticoid receptor gene in a Swedish family with pseudohypoaldosteronism type I (PHA1).
    Nyström AM; Bondeson ML; Skanke N; Mårtensson J; Strömberg B; Gustafsson J; Annerén G
    J Clin Endocrinol Metab; 2004 Jan; 89(1):227-31. PubMed ID: 14715854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.